StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TLRY

Tilray Brands, Inc.

TLRY Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗
$4.64
+0.10 +2.20%

Key statistics

from XBRL data in SEC filings
Market cap
$632M
Revenue (TTM)
$915M
Net income (TTM)
-$121M
EPS (TTM)
$-1.09
P/E ratio
Dividend yield
Free cash flow
-$102M
Cash
$226M
Total assets
$2.33B
Gross margin
28.4%
52-week range
$3.67 – $23.20

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-K Fiscal year ended 2026-05-31 Jul 28, 2026 8-K Results of operations (earnings release) Jul 28, 2026 8-K Unregistered sale of equity Jun 30, 2026 8-K Unregistered sale of equity Jun 9, 2026 8-K Other events Apr 21, 2026 8-K Entered a material agreement Apr 15, 2026 8-K Unregistered sale of equity Apr 15, 2026 10-Q Quarter ended 2026-02-28 Apr 1, 2026 8-K Results of operations (earnings release) Apr 1, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Other events Mar 2, 2026 10-Q Quarter ended 2025-11-30 Jan 8, 2026 8-K Results of operations (earnings release) Jan 8, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Nov 26, 2025 8-K Shareholder vote results Nov 19, 2025 8-K Regulation FD disclosure Nov 17, 2025 10-Q Quarter ended 2025-08-31 Oct 9, 2025 8-K Results of operations (earnings release) Oct 9, 2025 8-K Other events Sep 10, 2025 10-K Fiscal year ended 2025-05-31 Jul 29, 2025 8-K Results of operations (earnings release) Jul 28, 2025 8-K Unregistered sale of equity Jun 23, 2025 8-K Shareholder vote results Jun 10, 2025 8-K Unregistered sale of equity Apr 25, 2025 8-K Other events Apr 17, 2025 10-Q Quarter ended 2025-02-28 Apr 8, 2025 8-K Results of operations (earnings release) Apr 8, 2025 8-K Delisting notice or listing-rule failure Mar 25, 2025 8-K Unregistered sale of equity Mar 10, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Feb 26, 2025 8-K Other events Feb 7, 2025 8-K Unregistered sale of equity Feb 6, 2025 10-Q Quarter ended 2024-11-30 Jan 10, 2025 8-K Results of operations (earnings release) Jan 10, 2025 8-K Shareholder vote results Dec 19, 2024 8-K Director or officer change Dec 13, 2024 8-K Other events Dec 2, 2024 8-K Shareholder vote results Nov 21, 2024 8-K Other events Nov 6, 2024 8-K Entered a material agreement Nov 1, 2024 10-Q Quarter ended 2023-08-31 Oct 10, 2024